1
Mark E Williamson, Jerry W Newbrough, Jeffrey P Castleberry, Steve W Stracener: Ambulatory infusion pump. Baxter International, Mark Buonaiuto, Paul C Flattery, Jay Nichols, January 9, 1996: US05482446 (237 worldwide citation)

A medical infusion pump (10) using a pump chamber cassette (86) has a housing (20,22) defining a pump chamber cassette receptacle (84) and a pump driving mechanism (250) for propelling liquid through the pump chamber cassette. A door (50) holds the pump chamber cassette (86) within the cassette rece ...


2
Mark E Williamson, Jerry W Newbrough, Robert L Anderson, Jeffrey P Castleberry, Warren P Heim, Steve W Stracener: Pump chamber and valve assembly. Baxter International, Francis C Kowalik, Mark Buonaiuto, Paul Flattery, September 3, 1996: US05551850 (183 worldwide citation)

A medical infusion pump (10) using a pump chamber cassette (86) has a housing (20,22) defining a pump chamber cassette receptacle (84) and a pump driving mechanism (250) for propelling liquid through the pump chamber cassette. A door (50) holds the pump chamber cassette (86) within the cassette rece ...


3
Joseph Wong, Irwin B Levine: In-line drug delivery device for use with a standard IV administration set and a method for delivery. Baxter International, Mark Buonaiuto, Paul C Flattery, Jeffrey C Nichols, January 16, 1996: US05484406 (53 worldwide citation)

A drug delivery device (250) is provided for coupling a container (260) including a beneficial agent (262) to the device (250). The device (250) includes a substantially hollow member for housing a solution (256) wherein the hollow member includes an upper section (254) having flexible walls and a l ...


4
Allan E Titus, Douglas G Johnson: Premixed famotidine formulation. Baxter International, Mark Buonaiuto, Monique Morneault, July 22, 1997: US05650421 (3 worldwide citation)

A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4.5 to about 8.0, and a shelf life greater than 30 days.


5
James E Kipp, Mark J Doty, Christine L Rebbeck, Jan Y Eilert: Amiodarone-containing parenteral administration. Baxter International, Mark Buonaiuto, Robert Diehl, November 12, 2002: US06479541 (1 worldwide citation)

The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methane ...



Click the thumbnails below to visualize the patent trend.